PTPN22 targeting partners with 41BB/OX40 costimulation to overcome anti-PD1 resistance in pancreatic ductal adenocarcinoma

被引：0
|
作者：
Charmsaz, Soren
Gross, Nicole E.
Lee, Jae W.
Lin, Jianping
Hernandez, Alexei G.
Coyne, Erin M.
Shin, Sarah M.
Cannon, Courtney
Yuan, Xuan
Zhang, Zhong-Yin
Jaffee, Elizabeth M.
Ho, Won Jin
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 06期
关键词：
D O I：
10.1158/1538-7445.AM2024-5306
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5306
引用
收藏
页数：2
相关论文
共 3 条
  • [1] Targeting the Stroma to Enhance T-Cell Infiltration and Anti-tumor Response to Anti-PD1 Antibody in Pancreatic Ductal Adenocarcinoma
    Osipov, A.
    Zheng, L.
    PANCREAS, 2020, 49 (10) : 1422 - 1423
  • [2] TARGETING THE STROMA TO ENHANCE EFFECTOR MEMORY T CELL INFILTRATION AND ANTI-TUMOR RESPONSE TO ANTI-PD1 ANTIBODY IN PANCREATIC DUCTAL ADENOCARCINOMA
    Osipov, A.
    Zheng, L.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 : A59 - A60
  • [3] Targeting RAS/RAF/PI3K pathway for CD40 induction in melanoma cells to overcome resistance to anti-PD1 immunotherapies
    Yan, Chi
    Luo, Weifeng
    Chen, Sheau-Chiann
    Johnson, Douglas
    Ayers, Gregory
    Richmond, Ann
    JOURNAL OF IMMUNOLOGY, 2024, 212 (01):
1